123 related articles for article (PubMed ID: 17404580)
1. Polymorphisms of norepinephrine transporter and adrenergic receptor alpha1D are associated with the response to beta-blockers in dilated cardiomyopathy.
Nonen S; Okamoto H; Fujio Y; Takemoto Y; Yoshiyama M; Hamaguchi T; Matsui Y; Yoshikawa J; Kitabatake A; Azuma J
Pharmacogenomics J; 2008 Feb; 8(1):78-84. PubMed ID: 17404580
[TBL] [Abstract][Full Text] [Related]
2. Ser49Gly of beta1-adrenergic receptor is associated with effective beta-blocker dose in dilated cardiomyopathy.
Magnusson Y; Levin MC; Eggertsen R; Nyström E; Mobini R; Schaufelberger M; Andersson B
Clin Pharmacol Ther; 2005 Sep; 78(3):221-31. PubMed ID: 16153393
[TBL] [Abstract][Full Text] [Related]
3. A polymorphism in the endothelin-A receptor gene predicts survival in patients with idiopathic dilated cardiomyopathy.
Herrmann S; Schmidt-Petersen K; Pfeifer J; Perrot A; Bit-Avragim N; Eichhorn C; Dietz R; Kreutz R; Paul M; Osterziel KJ
Eur Heart J; 2001 Oct; 22(20):1948-53. PubMed ID: 11601839
[TBL] [Abstract][Full Text] [Related]
4. Association of beta-adrenergic receptor polymorphisms and progression to heart failure in patients with idiopathic dilated cardiomyopathy.
Forleo C; Resta N; Sorrentino S; Guida P; Manghisi A; De Luca V; Romito R; Iacoviello M; De Tommasi E; Troisi F; Rizzon B; Guanti G; Rizzon P; Pitzalis MV
Am J Med; 2004 Oct; 117(7):451-8. PubMed ID: 15464701
[TBL] [Abstract][Full Text] [Related]
5. Norepinephrine transporter polymorphisms T-182C and G1287A are not associated with alcohol dependence and its clinical subgroups.
Huang SY; Lu RB; Ma KH; Shy MJ; Lin WW
Drug Alcohol Depend; 2008 Jan; 92(1-3):20-6. PubMed ID: 17630229
[TBL] [Abstract][Full Text] [Related]
6. Polymorphisms of the beta-1 and beta-2 adrenergic receptors in Polish patients with idiopathic dilated cardiomyopathy.
Paczkowska A; Szperl M; Małek Ł; Mazurkiewicz Ł; Skóra E; Grzybowski J; Roszczynko M; Bilińska Z; Tesson F; Ruzyłło W
Kardiol Pol; 2009 Mar; 67(3):235-41. PubMed ID: 19378229
[TBL] [Abstract][Full Text] [Related]
7. Impact of beta1-adrenergic receptor polymorphisms on susceptibility to heart failure, arrhythmogenesis, prognosis, and response to beta-blocker therapy.
Biolo A; Clausell N; Santos KG; Salvaro R; Ashton-Prolla P; Borges A; Rohde LE
Am J Cardiol; 2008 Sep; 102(6):726-32. PubMed ID: 18773997
[TBL] [Abstract][Full Text] [Related]
8. Increased gene expression of collagen Types I and III is inhibited by beta-receptor blockade in patients with dilated cardiomyopathy.
Shigeyama J; Yasumura Y; Sakamoto A; Ishida Y; Fukutomi T; Itoh M; Miyatake K; Kitakaze M
Eur Heart J; 2005 Dec; 26(24):2698-705. PubMed ID: 16204268
[TBL] [Abstract][Full Text] [Related]
9. Synergistic polymorphisms of beta1 and alpha2C-adrenergic receptors and the influence on left ventricular ejection fraction response to beta-blocker therapy in heart failure.
Lobmeyer MT; Gong Y; Terra SG; Beitelshees AL; Langaee TY; Pauly DF; Schofield RS; Hamilton KK; Herbert Patterson J; Adams KF; Hill JA; Aranda JM; Johnson JA
Pharmacogenet Genomics; 2007 Apr; 17(4):277-82. PubMed ID: 17496726
[TBL] [Abstract][Full Text] [Related]
10. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
Lohmann FW
Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
[TBL] [Abstract][Full Text] [Related]
11. Interaction between cardiac sympathetic drive and heart rate in heart failure: modulation by adrenergic receptor genotype.
Kaye DM; Smirk B; Finch S; Williams C; Esler MD
J Am Coll Cardiol; 2004 Nov; 44(10):2008-15. PubMed ID: 15542284
[TBL] [Abstract][Full Text] [Related]
12. Beta1- and beta2-adrenergic receptor polymorphisms affect susceptibility to idiopathic dilated cardiomyopathy.
Forleo C; Sorrentino S; Guida P; Romito R; De Tommasi E; Iacoviello M; Pitzalis M
J Cardiovasc Med (Hagerstown); 2007 Aug; 8(8):589-95. PubMed ID: 17667029
[TBL] [Abstract][Full Text] [Related]
13. Identification of a genetic risk factor for idiopathic dilated cardiomyopathy. Involvement of a polymorphism in the endothelin receptor type A gene. CARDIGENE group.
Charron P; Tesson F; Poirier O; Nicaud V; Peuchmaurd M; Tiret L; Cambien F; Amouyel P; Dubourg O; Bouhour J; Millaire A; Juilliere Y; Bareiss P; André-Fouët X; Pouillart F; Arveiler D; Ferrières J; Dorent R; Roizès G; Schwartz K; Desnos M; Komajda M
Eur Heart J; 1999 Nov; 20(21):1587-91. PubMed ID: 10529327
[TBL] [Abstract][Full Text] [Related]
14. An interaction between the norepinephrine transporter and monoamine oxidase A polymorphisms, and novelty-seeking personality traits in Korean females.
Lee BC; Yang JW; Lee SH; Kim SH; Joe SH; Jung IK; Choi IG; Ham BJ
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Jan; 32(1):238-42. PubMed ID: 17920180
[TBL] [Abstract][Full Text] [Related]
15. The calcium channel blocker felodipine attenuates the positive hemodynamic effects of the beta-blocker metoprolol in severe dilated cardiomyopathy--a prospective, randomized, double-blind and placebo-controlled study with invasive hemodynamic assessment.
Braun M; Edelmann F; Knapp M; Schön S; Schwencke C; Simonis G; Borst M; Weinbrenner C; Strasser RH
Int J Cardiol; 2009 Feb; 132(2):248-56. PubMed ID: 18579230
[TBL] [Abstract][Full Text] [Related]
16. [Beta-receptor blockers in dilated cardiomyopathy].
Osterziel KJ
Dtsch Med Wochenschr; 1994 Nov; 119(46):1604-5. PubMed ID: 7956807
[No Abstract] [Full Text] [Related]
17. Beta-blockers influence the short-term and long-term prognostic information of natriuretic peptides and catecholamines in chronic heart failure independent from specific agents.
Frankenstein L; Nelles M; Slavutsky M; Schellberg D; Doesch A; Katus H; Remppis A; Zugck C
J Heart Lung Transplant; 2007 Oct; 26(10):1033-9. PubMed ID: 17919624
[TBL] [Abstract][Full Text] [Related]
18. Does tight heart rate control improve beta-blocker efficacy? An updated analysis of the noncardiac surgical randomized trials.
Beattie WS; Wijeysundera DN; Karkouti K; McCluskey S; Tait G
Anesth Analg; 2008 Apr; 106(4):1039-48, table of contents. PubMed ID: 18349171
[TBL] [Abstract][Full Text] [Related]
19. Impact of synergistic polymorphisms in adrenergic receptor-related genes and cardiovascular events in patients with dilated cardiomyopathy.
Ogimoto A; Okayama H; Nagai T; Suzuki J; Inoue K; Nishimura K; Shigematsu Y; Tabara Y; Miki T; Higaki J
Circ J; 2012; 76(8):2003-8. PubMed ID: 22664639
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of exercise-induced T wave changes in patients with idiopathic dilated cardiomyopathy before and after beta-blocker therapy.
Hara H; Niwano S; Hirasawa S; Sasaki T; Ikeda N; Izumi T
J Cardiovasc Electrophysiol; 2006 Aug; 17(8):865-70. PubMed ID: 16903965
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
